The Spanish Association of Orphan and Ultra Orphan Drug Laboratories (AELMHU) has published its Report on Access to Orphan Drugs in Spain for the second quarter of 2024. This publication, which analyzes the situation up to ... Read more
30-09-2024
Jury's decision for the AELMHU 2024 Awards
The Spanish Association of Orphan and Ultra Orphan Drug Laboratories (AELMHU) has published the jury's decision in the VI Edition of its Awards, aimed at recognizing the most significant contributions in the field of orphan and ultra orphan drugs.... Read more
24-07-2024
AELMHU and the Consejo General de Colegios Farmacéuticos (General Council of Pharmaceutical Associations)
The Spanish Association of Orphan and Ultra Orphan Drug Laboratories (AELMHU) has held a meeting with the General Council of Official Pharmaceutical Associations (CGCOF), with the aim of strengthening the collaboration between both entities and ... Read more
09-07-2024
II Conference on Advanced Therapies
Today, the Spanish Association of Orphan and Ultra Orphan Drug Laboratories (AELMHU) held the II National Conference "The Future of Advanced Therapies in Rare Diseases" in the Auditorium of the University Camilo José José ... Read more
01-07-2024
Visit to Sant Joan de Déu
The Spanish Association of Orphan and Ultra Orphan Drugs was able to visit the Hospital Sant Joan de Déu and the Casa de Sofia to learn first-hand about the SJD Únicas project, an essential component of the ... Read more
28-06-2024
II National Conference on Advanced Therapies
The Spanish Association of Orphan and Ultra Orphan Drugs (AELMHU) has announced the celebration of the II National Conference: The Future of Advanced Therapies in Rare Diseases. This event, sponsored by BioMarin, CSL Behring, Novartis, ... Read more